Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | VDR | P11473 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27129692 | 1.00 | ABHD6 (0.32) | ABHD6FAAHMGLLVDRCHRM4 | |
| SCHEMBL27034253 | 1.00 | ABHD6 (0.32) | ABHD6FAAHMGLLVDRCHRM4 | |
| SCHEMBL29090665 | 0.91 | ALOX15 (0.33) | VDR | |
| SCHEMBL14661800 | 0.87 | — | — | |
| SCHEMBL21401562 | 0.83 | L3MBTL1 (0.39) | ABHD6FAAHMGLL | |
| SCHEMBL21384531 | 0.83 | L3MBTL1 (0.39) | ABHD6FAAHMGLL | |
| SCHEMBL21384373 | 0.82 | GPR119 (0.40) | ABHD6FAAHMGLLCHRM1 | |
| SCHEMBL30845965 | 0.82 | GPR119 (0.40) | ABHD6FAAHMGLLCHRM1 | |
| SCHEMBL21401557 | 0.82 | GPR119 (0.40) | ABHD6FAAHMGLLCHRM1 | |
| SCHEMBL9993022 | 0.82 | CYP2C19 (0.35) | ABHD6FAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219464-A1 | PIPERAZINE AZASPIRO DERIVAVES | Pfizer Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230192654-A1 | PIPERAZINE AZASPIRO DERIVATIVES | PFIZER INC. | 2023-06-22 | — | — | US | disclosed |
| EP-3768669-B1 | PIPERAZINE AZASPIRO DERIVAVES | PFIZER (US) | 2023-01-25 | — | — | EP | disclosed |
| US-11524954-B2 | Piperazine azaspiro derivatives | PFIZER INC. (US) | 2022-12-13 | — | — | US | disclosed |
| US-20210024497-A1 | PIPERAZINE AZASPIRO DERIVAVES | PFIZER INC. | 2021-01-28 | — | — | US | disclosed |
| EP-3768669-A1 | PIPERAZINE AZASPIRO DERIVAVES | Pfizer Inc (US) | 2021-01-27 | — | — | EP | disclosed |
| WO-2019183636-A1 | PIPERAZINE AZASPIRO DERIVAVES | PFIZER INC. (US) | 2019-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192654-A1 | PIPERAZINE AZASPIRO DERIVATIVES | CHRM1, CHRM2, CHRM5 | ABHD6 4316/4885FAAH 2205/4885MGLL 3976/4885 |
| US-11524954-B2 | Piperazine azaspiro derivatives | CHRM1, CHRM2, CHRM5 | ABHD6 4316/4885FAAH 2205/4885MGLL 3976/4885 |
| US-20210024497-A1 | PIPERAZINE AZASPIRO DERIVAVES | CHRM1, CHRM2, CHRM5 | ABHD6 4252/4885FAAH 1826/4885MGLL 4377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.